Udg Healthcare (UDG) Stock Rating Reaffirmed by Peel Hunt

Share on StockTwits

Peel Hunt reaffirmed their buy rating on shares of Udg Healthcare (LON:UDG) in a research report released on Thursday, ThisIsMoney.Co.Uk reports.

A number of other research analysts also recently commented on UDG. Liberum Capital restated a buy rating on shares of Udg Healthcare in a research note on Tuesday, January 8th. Jefferies Financial Group downgraded Udg Healthcare to a hold rating and lowered their price objective for the stock from GBX 765 ($10.00) to GBX 620 ($8.10) in a research note on Friday, January 11th. Finally, Barclays upgraded Udg Healthcare to an overweight rating and lowered their price objective for the stock from GBX 770 ($10.06) to GBX 720 ($9.41) in a research note on Thursday, April 4th. Three investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. The company presently has an average rating of Buy and a consensus target price of GBX 780.57 ($10.20).

UDG traded up GBX 14 ($0.18) during trading on Thursday, reaching GBX 681.50 ($8.91). 1,025,110 shares of the company were exchanged, compared to its average volume of 981,360. The company has a market cap of $1.69 billion and a P/E ratio of 454.33. The company has a debt-to-equity ratio of 27.53, a current ratio of 2.02 and a quick ratio of 1.80. Udg Healthcare has a 52 week low of GBX 545 ($7.12) and a 52 week high of GBX 950.50 ($12.42).

About Udg Healthcare

UDG Healthcare plc, together with its subsidiaries, provides advisory, communication, commercial, clinical, and packaging services in the Republic of Ireland, the United Kingdom, North America, and internationally. The company operates in two segments, Ashfield and Sharp. The Ashfield segment offers commercialization services for the pharmaceutical and healthcare industry in the areas of advisory, communications, and commercial and clinical services.

See Also: How Does the Quiet Period Work?

Analyst Recommendations for Udg Healthcare (LON:UDG)

Receive News & Ratings for Udg Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Udg Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.